Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian-Dutch-English (IDEAL) collaborators by Nijjer, SS et al.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CLINICAL RESEARCH
Coronary artery disease
Coronary pressure and flow relationships
in humans: phasic analysis of normal and
pathological vessels and the implications for
stenosis assessment: a report from the Iberian–
Dutch–English (IDEAL) collaborators
Sukhjinder S. Nijjer1†, Guus A. de Waard2†, Sayan Sen1, Tim P. van de Hoef3,
Ricardo Petraco1, Mauro Echavarrı´a-Pinto4, Martijn A. van Lavieren3,
Martijn Meuwissen5, Ibrahim Danad2, Paul Knaapen2, Javier Escaned4, Jan J. Piek3,
Justin E. Davies1†, and Niels van Royen2†*
1Imperial College London, London, UK; 2VU University Medical Centre, Amsterdam, The Netherlands; 3Academic Medical Centre, Amsterdam, The Netherlands; 4Cardiovascular
Institute, Hospital Clı´nico San Carlos, Madrid, Spain; and 5Amphia Hospital, Breda, The Netherlands
Received 30 April 2015; revised 28 September 2015; accepted 27 October 2015; online publish-ahead-of-print 26 November 2015
See page 2081 for the editorial comment on this article (doi:10.1093/eurheartj/ehv688)
Background Our understanding of human coronary physiological behaviour is derived from animal models. We sought to describe
physiological behaviour across a large collection of invasive pressure and flow velocity measurements, to provide a bet-




Five hundred and sixty-seven simultaneous intracoronary pressure and flow velocity assessments from 301 patients
were analysed for coronary flow velocity, trans-stenotic pressure gradient (TG), and microvascular resistance
(MVR). Measurements weremade during baseline and hyperaemic conditions. Thewhole cardiac cycle and the diastolic
wave-free period were assessed. Stenoses were assessed according to fractional flow reserve (FFR) and quantitative
coronary angiography DS%. With progressive worsening of stenoses, from unobstructed angiographic normal vessels
to those with FFR ≤ 0.50, hyperaemic flow falls significantly from 45 to 19 cm/s, Ptrend, 0.001 in a curvilinear pattern.
Resting flow was unaffected by stenosis severity and was consistent across all strata of stenosis (Ptrend. 0.05 for all).
Trans-stenotic pressure gradient rose with stenosis severity for both rest and hyperaemic measures (Ptrend , 0.001 for
both). Microvascular resistance declines with stenosis severity under resting conditions (Ptrend , 0.001), but was
unchanged at hyperaemia (2.3+1.1 mmHg/cm/s; Ptrend ¼ 0.19).
Conclusions With progressive stenosis severity, TG rises. However, while hyperaemic flow falls significantly, resting coronary flow is
maintained by compensatory reduction of MVR, demonstrating coronary auto-regulation. These data support the transla-
tion of coronary physiological concepts derived from animals to patients with coronary artery disease and furthermore,
suggest that resting pressure indices can be used to detect the haemodynamic significance of coronary artery stenoses.
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Introduction
The physiological behaviour of human coronary stenoses has been
inferred from animal experiments that studied changes of flow vel-
ocity and pressure in the presence of artificially created stenoses.1–3
These experiments determined that stenoses created by external
constriction or ligation had a non-linear relationship between the
degree of coronary narrowing and trans-stenotic flow velocity
and pressure gradient.3 Early attempts to replicate this across pa-
tients with coronary artery disease were unsuccessful, presumably
due to the effect of atherosclerosis and cardiovascular risk factors
on other domains of the coronary circulation.4,5 Nevertheless, ani-
mal models continue to be used to describe human physiology.
Since plotting pressure–flow relationships can be challenging in
clinical practice, indices have been formulated to describe the im-
portance of stenoses.6,7 Those involving both pressure and flow vel-
ocity measurement have predominantly been used in a research
setting.7–10 Pressure-only measurements, being easier to perform,
have gained more common clinical application. Fractional flow re-
serve (FFR), a pressure-only hyperaemicmeasure is treated as a sim-
plified surrogate for flow based upon assessments in animals. It has
compelling outcome data and is widely advocated to guide coronary
assessment.11 Another newer pressure-only index, instantaneous
wave-free ratio (iFR)12,13 is measured under resting conditions, ob-
viating the need for hyperaemic vasodilators such as adenosine.
While the rationale for the hyperaemic physiological assessment
of coronary artery stenosis has been extensively validated, resting
stenosis assessment has been less extensively explored.
The aim of this study is to investigate the coronary pressure–flow
relationship in patients with and without angiographic evidence of
obstructive atherosclerosis under resting and hyperaemic condi-
tions. The IDEAL dataset is used to analyse 567 human coronary ar-
tery intracoronary pressure and flow velocity recordings to revisit
pressure–flow relationships in a large clinical cohort of patients




This study incorporates prospectively collected data from a total of 567
combined pressure and Doppler flow velocity measurements in 301 pa-
tients at the Amsterdam Medical Center Amsterdam, The Netherlands
(n ¼ 161), Imperial College London, UK (n ¼ 160), Hospital Clinico San
Carlos, Madrid, Spain (n ¼ 21), and VU University Medical Center,
Amsterdam, The Netherlands (n ¼ 225). All patients recruited were
scheduled for elective coronary angiography with physiological stenosis
assessment by FFR and gave written informed consent for acquisition of
additional physiological data for study purposes.
While acquisition methodology of physiological data was similar for
all participating centres, the study protocol was different for each cen-
tre. Individual centre recruitment criteria are shown in Supplementary
material online. Composite exclusion criteria were severe valvular heart
disease, weight .200 kg (determined by the catheter laboratory table
capacity), previous coronary artery bypass surgery, vessels with angio-
graphically identifiable myocardial bridging or collateral arteries and ves-
sels with a previous myocardial infarction. Patients with an acute
myocardial infarction within 48 h were not included.
Coronary catheterization
Coronary angiography and pressure–flow assessments of coronary
stenoses were performed using conventional approaches.14 Intracoron-
ary nitrates (200–300 mg) were administered in all cases. Contempor-
ary combined pressure and Doppler flow velocity wires (ComboWire
XT, Volcano Corporation, San Diego, CA, USA) were used and the dis-
tal pressure sensor was equalized with the aortic guiding pressure at the
coronary ostium before distal passing of the wire. Measurements were
made distal to the stenosis at least three vessel diameters from the sten-
osis. Adenosine was administered by intravenous infusion in 234 mea-
surements (140 mg/kg/min) and by intracoronary bolus injection in
333 measurements (60–150 mg).
Doppler signals were optimized carefully to ensure adequate tracking
profiles were observed. Electrocardiogram (ECG), pressures, and
flow velocity signals were directly extracted from the device console
(ComboMap, Volcano Corporation, San Diego, CA, USA). At the
end of each recording, the pressure sensor was returned to the catheter
tip to assess pressure drift. If pressure drift was identified (.2 mmHg)
measurements were repeated or corrected for upon analysis. Data
were analysed off-line, using a custom software package designed with
MATLAB (Mathworks, Inc, Natick, MA, USA). A total of 653 cases
were originally acquired, but 86 vessels (13.2%) were excluded because
of poor Doppler flow velocity or uncontrollable pressure drift leaving
567 vessels for final analysis. Resting indices were calculated at a time
of stability, without any preceding injection of contrast or saline. Hyper-
aemic indices were calculated during stable hyperaemia, excluding
ectopy and conduction delay.
Stenosed and reference vessels
Five hundred and sixty-seven coronary assessments were made. Three
hundred and sixty-six vessels had an angiographically visible stenosis.
Two hundred and one vessels had no angiographic obstruction as deter-
mined by the physician performing the procedure and confirmed by two
observers (S.N. and G.d.W.).
Stenosis stratification
Both FFR and diameter stenosis assessed by quantitative angiography
(QCA) were used to stratify stenosis severity. Myocardial FFR measure-
ments were performed, using the ratio of distal coronary pressure to
proximal pressure during stable hyperaemia. Quantitative angiography
parameters (diameter stenosis % (DS%), minimal lumen diameter, min-
imal lumen area, area stenosis, and lesion length) were calculated
for stenoses using dedicated workstations (CAAS II, Pie Medical,
Maastricht, The Netherlands or McKesson, San Francisco, USA), which
performed automated contour analysis with manual correction limited
to situations causing artefacts or very tight stenoses.
Calculation of hemodynamic parameters
Flow velocity was assessed over four periods: first, flow velocity at rest
over the entire cardiac cycle and secondly over the specific diastolic
wave-free period (during which iFR is calculated), which was detected
using the ECG signals. Flow velocity was also assessed during adenosine-
mediated hyperaemia over the whole cardiac cycle and the wave-free
period. The same two time periods in the cardiac cycle, both at rest
and hyperaemia, were used to derive measures of microvascular resist-
ance (MVR) and trans-stenotic pressure gradient (TG). Figure 1 shows
an example of simultaneous pressure and flow velocity measurements,
together with the cardiac phases over which the study parameters were
calculated.
Microvascular resistance (mmHg/cm/s) is calculated by dividing distal
pressure (Pd, mmHg) by flow velocity (cm/s). When calculated for the
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whole cardiac cycle, values of pressure and flow velocity were averaged
over an entire heart beat; typically measurements were made as an aver-
age over five beats. When calculated over the wave-free period, pres-
sure and flow velocity data were constrained to that averaged over
the diastolic wave-free period.
For all measurements, computation of the parameters was per-
formed by a single analyst blinded to the coronary angiograms or patient
specific factors, using an automated MATLAB script (MathWorks,
Natick, MA, USA) with built-in wave-free algorithm (developed at
Imperial College, London and licensed to Volcano Corp, San Diego,
CA, USA), as previously described.12
Statistical analysis
Categorical data are presented as numbers and percentages, while con-
tinuous data are presented as mean+ standard deviation. Regression
analysis was performed between quantitative values to determine the
coefficient of determination. Curve fitting was achieved by applying
2nd and 3rd order and fractional polynomials. Association between
flow velocity (dependent variable) and strata of stenosis severity were
assessed by analysis of variance (ANOVA) with correction for repeated
measures followed by post hoc pairwise methods, including Bonferroni,
Sidak, and Scheffe; this was followed by Tukey HSD testing where ap-
propriate. Findings were confirmed using Kruskal–Wallis testing to
avoid assumptions of normality. Trends across strata were assessed
with regression and a non-parametric extension of theWilcoxon signed
rank test (nptrend) and also with generalized estimating equations; in all
analyses, the findings were the same suggesting a robust analysis. The
analysis was repeated for TG or MVR as dependent variables. A P-value
of ,0.05 was considered statistically significant. All statistical analyses
were performed using Stata 11.2 (StataCorp, TX, USA).
Results
Patient and vessel characteristics
Five hundred and sixty-seven coronary assessments were derived
from 301 patients (age 53.5+ 22.3 years old, 59% male, Table 1).
No patients had hypertrophic cardiomyopathy or gross hyper-
trophy secondary to hypertension. Characteristics of patients and
vessels is shown per participating centre in Supplementary material
online, Table S1. Three hundred and sixty-six (65%) were from
vessels with a visible stenosis, with 85 measurements taken post-
percutaneous coronary intervention (PCI). Two hundred and one
(35%) measurements were from vessels free from angiographic
disease, which served as reference vessels. For the 366 vessels
with a stenosis, the FFR ranged from 0.28 to 1.07.
The distribution of stenoses was consistent with that typically
found in clinical practice with mean FFR 0.81+ 0.16 and mean
QCA diameter stenosis of 48.5+25.2%, indicating that the majority
was of intermediate severity (Figure 2). In the 201 reference vessels,
FFR ranged from 0.85 to 1.08 with a mean FFR of 0.96+ 0.04. Over-
all, these findings confirmed the absence of obstructive epicardial
disease. In 23 (11%) of the reference cases, an FFR of .0.80
and ≤0.90 was documented, suggesting the existence of abnormal
epicardial conductance. A value of FFR. 1.0 was noted in 30 ves-
sels despite careful drift assessment. This predominantly occurred
in the LCx (18 cases, 60%) and in reference vessels (26 cases,
87%) and was likely due to hydrostatic consequences of the wire
being in a distal vessel below the position of the transducer. For
the stenosed vessels, the relationship between FFR and anatomical
Figure 1 Top panel: example of simultaneous coronary pressure and flow velocity measurement obtained distal to an left anterior descending
stenosis of 69% diameter stenosis by quantitative angiography with FFR of 0.79. Bottom panel: the analysed phases during the resting and hyper-
aemic state are shown.
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DS%demonstrated significant scatter (R2 ¼ 0.23, P, 0.01; Figure 3).
Similar findings were noted when plotting FFR and anatomical
minimal luminal diameter (R2 ¼ 0.19, P, 0.001; Supplementary
material online, Figure S1).
Whole cycle pressure–flow velocity
relationships
A given stenosis has a unique curvilinear relationship between
the flow velocity and the TG across the stenosis. Pressure–
flow velocity relationships over the whole cardiac cycle were
calculated both during resting and hyperaemic conditions, and
averaged for each stratum of stenosis severity. Mean pressure–
flow velocity relationships were stratified according to DS%
(Figure 4, left panel) and according to FFR classification (Figure 4,
right panel).
Diastolic pressure and flow velocity
relationships
Pressure–flow velocity relationships were calculated over the
wave-free period specifically, both at rest and hyperaemia. For
each stratification, these relationships closely fit the pressure–
flow velocity curves derived from whole-cycle physiology (Figure 4).
Resting wave-free period flow velocity was significantly higher
than whole cycle resting conditions (P, 0.05 for each FFR or
QCA stratum), and consistently produced a higher TG, both at
rest and during hyperaemia (P, 0.05 for each FFR or QCA stra-
tum). The only exception was TG in reference vessels and FFR .
0.91 under resting conditions, where TG was equivalent for whole
cycle and wave-free period (1.5+0.2 vs. 1.6+0.2 mmHg, respect-
ively; P ¼ 0.53, and 1.1+ 0.1 vs. 1.3+ 0.1 mmHg; P ¼ 0.08) as
there was no stenosis sufficient to cause diastolic pressure separ-
ation. Under hyperaemic conditions, both a consistently higher
flow velocity and TG were found during the wave-free period
than during whole cycle (P, 0.05 for each FFR or QCA stratum).
Influence of stenosis severity on coronary
flow velocity
Resting flow velocity stratified according to angiographic and FFR
strata is depicted in Figure 5, upper panel. Numerical relationships
between stenosis severity and the analysed parameters, as well as
the physiological indices, are shown in Tables 2 and 3. Resting flow
velocity has no significant relationship with stenosis severity
whether assessed by FFR or anatomical severity (Ptrend ¼ 0.16).
Hyperaemic flow velocity, over the whole cycle and the wave-free
period, shows a strong statistical association and trend to decline
with incremental stenosis severity (P, 0.001 for all assessments).
Microvascular resistance (Figure 5, middle panel) measured at rest
showed highly significant trends to fall with increasing stenosis se-
verity, during both whole cycle and wave-free period specifically
(Ptrend , 0.001). Hyperaemic MVR over the whole cycle was low
for all stenosis severities, but showed a trend to increase in the
most severe strata of stenosis severity (Ptrend ¼ 0.01). This trend
was not observed during the wave-free period under hyperaemic
conditions, which remained consistent across all strata of stenosis
severity (Ptrend ¼ 0.89 for FFR and Ptrend ¼ 0.82 for anatomical
stratification). The trend toward higher values of hyperaemic MVR
over the whole cycle but not during the wave-free period, arises
from an increasing MVR under the systole specifically (Supplemen-
tary material online, Figure S2). Findings shown in Figure 5 are main-
tained when post-PCImeasurements are excluded or when only the
post-PCI measurements are analysed (Supplementary material on-
line, Figure S3).
In contrast, TG (Figure 5, lower panel) whether measured at rest
or hyperaemia, had strong and significant relationships with stenosis
severity and followed identical trends, also for the wave-free period
(Ptrend , 0.001 for all assessments). Hyperaemic TG was strongly
related to FFR (R2 ¼ 0.95, P, 0.001). The behaviour of flow,
MVR and TG over the whole cycle under resting conditions for
the entire study cohort is summarized in Figure 6.
A natural incremental hierarchy exists between the physiological
states assessed: resting whole cycle, resting wave-free period,
hyperaemic whole cycle and hyperaemic wave-free period
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Table 1 Demographics and stenosis characteristics
N or mean % or standard
deviation
Patients 301




Current or ex-smoker 128 43%
Diabetes Mellitus 67 22%
Chronic renal impairment 5 2%
Family history of CAD 129 43%
Previous myocardial infarction 34 11%
Impaired LV function EF, 30% 2 0.7%
Stable angina 290 96%
Unstable angina 11 4%
Vessels 567
Angiographic stenosis 366 65%
Angiographically unobstructed 201 35%
Coronary artery
Left Anterior Descending 277 49%
Left Circumflex 172 30%
Right Coronary Artery 118 21%
Adenosine administration
Central intravenous 234 41%
Intracoronary bolus 333 59%
Coronary stenoses
% Diameter stenosis 46.0 21.3
% Area stenosis 68.9 22.8
Minimal lumen diameter (mm) 1.47 0.75
Minimal lumen area (mm2) 2.09 2.21
Stenosis length (mm) 17.0 12.5
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physiology. This was true for flow velocity and TG (P, 0.001
for both), while for MVR the same hierarchy exists in reverse
(P, 0.001). When stenoses had diameter stenosis .90% or
FFR ≤ 0.50, the hierarchy was no longer valid with resting flow
velocity exceeding hyperaemic and MVR being lower at rest than
during hyperaemia.
Anatomical stenosis severity
When analysed according to area stenosis or minimal lumen diam-
eter the same physiological outcomes for flow velocity, MVR and
TG were observed (Supplementary material online, Table S1) as
when analysed according to FFR or DS%. When data were analysed
according to lesion length, resting flow velocity decreased numeric-
ally slightly but statistically significantly with increasing stenosis
length (Supplementary material online, Figure S4). Very long lesion
lengths were the main contributor to this trend. In stenoses up to
40 mm long, resting wave-free flow velocity was preserved at
24.1+ 12.6 cm/s; in stenoses over 40 mm, flow velocity was
19.1+ 7.9, creating a significant trend (P ¼ 0.01) although not a sig-
nificant difference in mean values by ANOVA (P ¼ 0.62) or T-test
(P ¼ 0.15). The same was true for whole cycle resting flow velocity
(18.3+ 8.7 vs. 15.4+ 1.9 cm/s, P ¼ 0.23). Hyperaemic flow vel-
ocity similarly diminished from 39.4+ 22.4 to 26.7+ 18.8 cm/s,
demonstrating a strong trend. Microvascular resistance appeared
to be unrelated to lesion length, with no significant trends
noted for rest or hyperaemia. Trans-stenotic pressure gradient
was strongly related to length for all four physiological states
(Ptrend , 0.001 for all). Minimal lumen diameter and area were in
Figure 2 Distribution of the coronary arteries measured stratified according to percentage of diameter stenosis % (upper panel) and fractional
flow reserve (lower panel).
Figure 3 Distribution of percentage of diameter stenosis and
fractional flow reserve in stenoses. Despite a significant inverse
correlation between percentage of diameter stenosis and fraction-
al flow reserve, a substantial variability between the two para-
meters is noted (R2 ¼ 0.23, P, 0.01). The curve is fitted by
second-order polynomial.
Coronary pressure and flow relationships in humans 2073
keeping with results as stratified according to FFR or DS% (Supple-
mentary material online, Table S2).
Overall trends and relationships observed remain unchangedwhen
data are stratified according to the presence of diffuse and focal dis-
ease (Supplementary material online, Figure S5) or according to singu-
lar and serial stenoses (Supplementary material online, Figure S6).
Adenosine administration route
Stratification of data by adenosine administration route according
to FFR showed findings in keeping with the overall dataset for
flow velocity and TG (Ptrend, 0.001 for all phases) (Supplementary
material online, Figure S7). Hyperaemic whole cycle MVR significant-
ly increased with progressive stenosis severity for intracoronary
administration (Ptrend ¼ 0.04), but remained consistent for intraven-
ous administration (Ptrend ¼ 0.35). During the wave-free period,
hyperaemic MVR was consistent for the intracoronary route
(Ptrend ¼ 0.17), but showed a trend to being lower with progressive
stenosis severity with intravenous adenosine (Ptrend ¼ 0.03).
Discussion
In this study, we describe the relationship between coronary flow
velocity, TG, and MVR, estimated from measurements obtained
over the whole cardiac cycle or selectively within the wave-free per-
iod, under resting and hyperaemic conditions.
Firstly, we show that non-hyperaemic flow velocity remains con-
stant across the full spectrum of stenosis severities. Secondly, this
preservation of flow velocity is mediated by a reduction in resting
MVR in response to increasing stenosis resistance. Thirdly, the main-
tenance of resting flow velocity occurs at the expense of distal cor-
onary pressure, which falls with widening TG as stenosis severity
increases. The capacity for resting gradients to increase while pre-
serving flow velocity lends support to clinical use of invasive resting
coronary pressure assessment to determine functional stenosis sig-
nificance. Finally, we provide reference values of parameters used
in physiological assessment of the coronary circulation stratified
according to stenosis severity (Tables 2 and 3).
Auto-regulation ensures that resting
blood flow remains stable
Maintenance of resting coronary flow is regulated by endogenous
adenosine release, changes in intrinsic myogenic tone, endothelial
cell signalling and neurohumoral control, which combine to produce
continuous auto-regulatory adaption of arteriolar vessel diameter.15
In this study, we use invasively measured resting flow velocity and
found that this was stable in human coronary arteries across a
Figure 4 Relationships between trans-stenotic pressure gradient and flow velocity for coronaries grouped by stenosis severity (left panel ac-
cording to anatomical severity by percentage of diameter stenosis, and right panel according to physiological severity by fractional flow reserve).
Relationships are described by trans-stenotic pressure gradient ¼ A*flow + B*flow2 and can be fitted by three points: the zero TG—zero flow
crossing, the mean trans-stenotic pressure gradient and flow during whole cycle at rest, and during hyperaemia. Trans-stenotic pressure gradient
and flow during the wave-free period closely follow these relationships, both at rest and during hyperaemic conditions. Curves are fitted by
second-order polynomials.
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wide range of stenosis severities. While the resistance imposed by a
stenosis rises according to the Hagen-Poiseuille equation,16 we ob-
serve a reduction in MVR to compensate (Figure 6 summarizes the
results for whole cycle resting conditions). This reduction is closely
related to stenosis severity keeping resting flow stable and there-
fore, for the majority of moderate stenoses, a vasodilator reserve
should be expected. This is observed by a reduction in MVR in
the presence of a hyperaemic agent, such as adenosine. For stenoses
with very little physiological impact, a large vasodilatory reserve is
present meaning a large potential increase in flow during hyper-
aemia. In more significant stenoses, however, vasodilatory reserve
will become progressively exhausted, with limited increase in flow
response to an exogenous vasodilator. When a critical stenosis se-
verity is reached (likely to be exceeding 85–90% diameter by formal
QCA measurement, or FFR values ,0.60), coronary auto-
regulation becomes saturated with limited vasodilatory response
to exogenous agents. When a stenosis is beyond this critical point,
resting flow velocity is expected to fall. Clinically, this may manifest
as angina on increasingly lower levels of exertion.
Anatomical and physiological markers
of stenosis severity
Cursory assessment of Figure 4may suggest that FFR and anatomical
classification of stenoses are equivalent as the same patterns of
change in flow and MVR are observed. However, as shown by
many authors, there is a limited relationship between FFR and ana-
tomical severity, which is confirmed in this cohort (Figure 2). The as-
sessment is presented, not to state that anatomy and physiology are
equivalent, rather because the overall trends are so strong that they
are preserved even when the random scatter of the FFR-DS% rela-
tionship limits the potential relationship. Since anatomical assess-
ment of stenoses remains mainstay and is readily understood by
clinicians, it is appropriate to consider the underlying physiological
response to anatomical parameters, despite the crude limitations
of diameter stenosis. When study outcomes are analysed according
to other parameters that describe lesion tightness (minimal lumen
diameter, minimal lumen area, and area stenosis) similar findings
are noted. This is also true for the presence of diffuse compared
with focal disease and singular compared with serial stenoses.
Figure 5 Behaviour of phasic coronary flow velocity, microvascular resistance (MVR) and (TG) according to stenosis severity (left panel diam-
eter stenosis byQCA, and right panel by FFR). Parameters are shown for resting and hyperemic conditions, both during whole cycle and wave-free
period only. Curves are fitted by second-, third-order, and fractional polynomials.
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Resting flow velocity showed a trend to falling with very long lesion
lengths (over 40 mm) but only showed a small change, while hyper-
aemic flow diminished significantly. Figures 4 and 5 visually show that
when stratified according to DS%, a remarkable overlap with re-
spect to the TG for the 50–59 and 60–69% groups as well as the
70–79 and 80–89% groups is present. This observation reinforces
that in stenosis of intermediate severity, physiological assessment is
required to inform on haemodynamic significance.
The use of resting parameters to assess
stenoses
The stability of resting flow velocity for the majority of stenoses
means that resting flow alone cannot distinguish between stenosis
severities. However, since distal coronary pressure falls with in-
creasing stenosis severity, a combined pressure and flow velocity
measurement such as baseline stenosis resistance or a resting
pressure-only index such as iFR, can distinguish stenosis severity.
This implies that non-invasive imaging modalities such as positron
emission tomography, that measure myocardial perfusion without
knowledge of distal coronary pressure, require induction of the
hyperaemic state to yield satisfactory diagnostic accuracy.17
The change in resting TG is predominantly driven by a change in
MVR and resistance imposed by the stenosis. Since the impact of
physiological vasodilation at rest on the proximal driving pressure
is negligible, changes in distal pressure represent the true physio-
logical impact of the stenosis on the distal coronary bed. Small gra-
dients at rest suggest little compensatory vasodilatation is required,
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Table 2 Flow velocity, TG, MVR and physiological indices according to lesion severity defined by FFR
















Resting whole cycle 14.8 6.3 15.5 7.1 18.6 6.7 21.9 12.1 18.9 8.7 19.1 8.4
Resting wave-free period 18.7 7.4 20.3 10.4 24.6 10.1 29.1 18.3 25.4 13.2 25.1 11.4
Hyperemic whole cycle 18.5 10.3 22.8 13.6 28.3 13.7 36.9 18.9 38.9 18.0 48.2 23.7
Hyperemic wave-free
period
21.0 10.8 25.7 14.6 34.1 16.9 45.0 24.6 50.4 24.8 61.4 28.0
Trans-stenotic gradient (mmHg)
Resting whole cycle 45.6 19.7 26.0 11.8 15.5 8.6 9.81 5.0 5.19 3.06 1.17 2.32
Resting wave-free period 55.5 20.3 35.1 15.8 20.7 12.3 13.2 7.56 6.88 4.01 1.48 2.43
Hyperemic whole cycle 54.6 12.1 42.6 7.86 30.17 6.14 22.2 4.63 13.0 4.71 4.71 3.19
Hyperemic wave-free
period
61.1 11.0 51.2 8.49 37.9 8.40 30.4 7.37 17.6 5.65 6.34 4.25
Microvascular Resistance (mmHg/cm/s)
Resting whole cycle 4.20 1.57 5.55 2.40 5.04 2.03 5.61 4.34 5.80 2.40 6.09 2.39
Resting wave-free period 2.04 0.83 3.22 1.62 3.19 1.52 3.76 3.01 3.93 1.82 4.27 1.79
Hyperemic whole cycle 2.65 1.19 2.97 1.55 2.37 0.88 2.36 1.37 2.32 1.10 2.20 1.12
Hyperemic wave-free
period
1.22 0.56 1.55 0.90 1.37 0.62 1.41 0.88 1.45 0.81 1.49 0.86
Indices
Pd/Pa 0.56 0.15 0.74 0.11 0.84 0.07 0.91 0.05 0.95 0.03 0.99 0.02
iFR 0.39 0.18 0.60 0.17 0.76 0.12 0.84 0.10 0.92 0.05 0.98 0.03
FFR 0.42 0.06 0.54 0.03 0.66 0.03 0.75 0.03 0.85 0.03 0.95 0.03
HSR (mmHg/cm/s) 3.92 2.36 2.49 1.30 1.23 0.46 0.78 0.51 0.40 0.21 0.12 0.11
BSR (mmHg/cm/s) 3.83 2.58 2.02 1.25 0.88 0.44 0.55 0.44 0.32 0.23 0.07 0.16
CFR 1.26 0.44 1.51 0.69 1.61 0.71 1.81 0.54 2.16 0.74 2.62 0.88
Anatomical parameters
% Diameter stenosis 71.3 12.4 65.0 13.3 60.0 18.6 51.8 18.0 43.3 18.7 33.4 18.6
% Area stenosis 90.1 8.36 87.8 9.26 78.0 19.0 77.2 17.7 66.7 22.6 57.7 22.6
Minimal lumen diameter
(mm)
0.80 0.39 0.93 0.29 1.01 0.42 1.20 0.46 1.53 0.72 1.87 0.79
Minimal lumen area
(mm2)
0.63 0.55 0.76 0.46 0.94 0.83 1.26 0.99 2.23 2.27 3.13 2.57
Stenosis length (mm) 26.7 16.1 32.4 18.1 20.9 18.2 19.5 13.3 15.0 9.05 12.9 8.79
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Table 3 Flow velocity, TG, MVR and physiological indices according to lesion severity defined by anatomical stenosis severity (% diameter stenosis)








SD QCA ≤ 49% SD Reference SD
Flow Velocity (cm/s)
Resting whole cycle 16.4 8.02 17.5 6.52 14.9 7.60 19.4 9.63 17.7 9.0 20.0 8.9 17.8 6.9
Resting wave-free period 23.7 12.6 21.4 7.63 19.5 10.9 25.3 14.4 23.1 12.1 26.5 12.8 23.3 10.2
Hyperemic whole cycle 24.7 17.9 24.1 11.0 23.5 12.2 31.1 14.2 35.0 19.0 45.4 22.3 44.9 16.0
Hyperemic wave-free period 28.8 19.2 27.7 11.5 28.8 16.9 38.6 19.5 44.4 25.0 57.8 27.9 58.1 21.6
Trans-stenotic gradient (mmHg)
Resting whole cycle 34.7 26.1 29.5 27.2 22.8 19.1 13.4 16.1 8.10 9.36 4.42 4.97 1.53 2.51
Resting wave-free period 47.4 31.9 35.9 29.8 28.8 22.4 17.9 19.3 10.8 12.7 5.64 6.72 1.58 2.82
Hyperemic whole cycle 41.9 18.5 37.5 23.2 32.4 18.2 24.9 17.9 18.0 12.4 10.8 7.72 3.55 4.02
Hyperemic wave-free period 52.1 18.0 43.1 23.5 39.3 19.3 31.3 19.4 23.5 15.2 14.2 10.1 4.04 5.28
Microvascular Resistance (mmHg/cm/s)
Resting whole cycle 4.9 2.37 4.22 1.60 5.50 2.29 5.30 2.13 6.27 3.55 5.73 2.46 6.16 2.33
Resting wave-free period 1.93 0.31 2.45 0.97 3.38 1.91 3.41 1.61 4.25 2.51 3.92 1.85 4.38 1.83
Hyperemic whole cycle 2.84 1.91 2.65 1.28 2.69 0.99 2.52 1.10 2.56 1.50 2.14 1.01 2.18 0.80
Hyperemic wave-free period 1.07 0.37 1.44 0.67 1.49 0.71 1.47 0.71 1.58 1.08 1.38 0.75 1.48 0.62
Indices
Pd/Pa 0.68 0.21 0.72 0.21 0.77 0.19 0.87 0.15 0.92 0.10 0.96 0.05 0.98 0.03
iFR 0.51 0.28 0.60 0.27 0.67 0.24 0.80 0.21 0.87 0.15 0.93 0.08 0.98 0.03
FFR 0.55 0.16 0.60 0.17 0.64 0.18 0.73 0.17 0.80 0.14 0.88 0.09 0.96 0.04
HSR (mmHg/cm/s) 3.33 3.52 2.34 2.60 1.22 1.50 0.78 1.03 0.78 1.03 0.32 0.32 0.09 0.10
BSR (mmHg/cm/s) 3.26 3.32 2.22 2.68 0.91 1.31 0.55 0.79 0.55 0.79 0.25 0.27 0.09 0.17
CFR 1.37 0.38 1.36 0.36 1.65 0.67 1.67 0.59 2.12 0.85 2.39 0.86 2.64 0.76
Hyperemic stenosis resistance (HSR) is defined as the ratio between the TG and flow velocity under hyperemic conditions, while baseline stenosis resistance (BSR) is calculated the same way but under resting conditions instead. Coronary flow











while large gradients indicate substantial compensation. For a sten-
osis to have a physiological impact upon the vessel, it should there-
fore have a gradient that is detectible at rest and the induction of
hyperaemia will only exacerbate this gradient. Stenoses without a
resting gradient which manifests only upon vasodilator administra-
tion more likely represents a situation in which the microcirculatory
bed retains the capacity to dilate significantly and high flow velocities
can be generated across a trivial stenosis with subsequent turbu-
lence and pressure loss by the Bernoulli phenomenon.18 These
changes may manifest as a high coronary flow reserve (CFR), but
a low FFR value. Human data with 10-year follow-up confirm that
when such patients are deferred from PCI, the clinical event rate
remains low, demonstrating a clear paradox between hyperaemic
measurements of pressure and flow.19
Microvascular remodelling
Resting MVR reduces with increasing stenosis severity. Theoretical-
ly, microcirculatory angiogenesis and arteriogenesis could explain
this.20 However, if this phenomenon applies, it would not be re-
stricted to the resting situation and a substantial reduction in MVR
would remain during hyperaemia in severe stenoses. Our results in-
dicate that this is not the case and instead we confirm observations
from smaller studies, that hyperaemic MVR increases in critical sten-
oses.8,10,21 The increased hyperaemic MVR in severe stenoses is pri-
marily a systolic phenomenon (Supplementary material online,
Figure S2). We presume this observed rise in hyperaemic MVR,
can be attributed to the contribution of collateral circulation. Be-
cause collateral arteries connect with the receiving vessel distal to
the position of the pressure–flow wire, flow supplied by the collat-
eral arteries will not be detected, while collateral pressure is trans-
mitted through the vessels and can be detected by the wire.
Microvascular resistance is calculated as the ratio of distal pressure
(elevated by collateral supply) and flow, and the calculated MVR will
falsely rise accordingly.22 Naturally, when using whole cycle pres-
sure values, the contribution of the elevated pressures is higher
than when using the lower diastolic pressure values as collateral
pressure is elevated mainly during systole and much less so during
diastole.23 Moreover, in the intracoronary adenosine subgroup, a
trend was observed towards higher MVR during hyperaemia whole
cycle, while in the intravenous adenosine subgroup, hyperaemic
whole cycle MVR was consistent across stenosis severities. In the
intravenous subgroup, collateral supply may be diminished due to
the coronary steal phenomenon during hyperaemia and thereby
the MVR in these severe stenoses remains at normal values. How-
ever, this analysis has the limitation that coronary steal phenomenon
might still apply in the intracoronary subgroup for the left coronary
artery. Further work to assess the collateral flow or pressure during
diastole is required to understand this in detail.
Clinical implications
In this study, we provide flow velocity and resistance data from a
wide spectrum of coronary stenoses and reference vessels. These
data are valuable for accurate development and improvement of
computer flow dynamics models. For current flow models, such
as CT-FFR, data were derived from animals and small human studies
without significant disease.24,25 Our data demonstrate that unob-
structed vessels have a mean CFR of 2.64+0.76 in contrast to old-
er data informing CT-FFR, which assumes flow rises of 3.5-fold.30
Similarly, early CT systems assume resistance falls by 4.5-fold with
adenosine, while our data show whole cycle MVR is reduced by
2.8-fold.
Secondly, the data presented here provide reference values
stratified according to stenosis severity for the most commonly
used physiological indices. Exploration of less commonly used
physiological parameters such as the instantaneous hyperaemic dia-
stolic velocity–pressure slope (IHDVPS) and zero-flow pressure
(ZFP) may be of future interest to better indicate their clinical
applicability.
Finally, the data support the concept that stenosis interrogation
under resting conditions, as suggested by iFR, BSR, or baseline
Pd/Pa
10,12,13 has clinical utility beyond comparisons of classification
match with hyperaemic measures. Furthermore, our findings dem-
onstrate that the wave-free period consistently provides a higher
flow velocity and a lower MVR than assessment over the whole
cardiac cycle at rest. This means that wave-free period gradients
are consistently larger than over the whole cycle and iFR may pro-
vide greater sensitivity in moderate stenoses when compared with
baseline Pd/Pa. To provide a definitive answer to which physiological
index is preferable, randomized clinical outcome data are needed.
Conclusion
This large multicentre study of coronary pressure–velocity mea-
surements shows that with progressive stenosis severity, TG rises,
while resting coronary flow is maintained by compensatory reduc-
tion of MVR. This suggests that resting pressure indices can be used
to detect the haemodynamic significance of coronary artery sten-
oses. Our results confirm the applicability of the general principles
of coronary physiology determined in animals to patients with ath-
erosclerotic lesions. The main difference observed is a relatively
blunted response to hyperaemia as flow velocity rose to half what
has been observed in animal models in vessels with ,50% diameter
stenosis.
Figure 6 Mean TG, flow velocity and MVR data under resting
conditions over the whole cardiac cycle, stratified according to
angiographic stenosis severity. With progressive stenosis severity,
TG increases, while flow velocity is maintained at a stable level by
progressive compensatory reduction of MVR. Curves are fitted by
2nd, 3rd order and fractional polynomials.
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Limitations
This study has a number of limitations. Volumetric flow was not as-
sessed because of the limitations of accurate stenosis and vessel di-
mension calculation, as well as determining the mass of the
subtended myocardium which can only be estimated from angio-
graphic parameters. Since vessels taper, flow velocity will fall less
than volumetric flow and without knowledge of subtended mass,
flow velocity might be preferable to volumetric flow.26–28
Wedge pressure was not routinely measured and therefore de-
finitive assessment of the impact of collaterals on the results cannot
be made. However, measurements were not made in vessels with
visible collaterals.
While reference vessels were free of angiographic disease,
intravascular ultrasound studies demonstrated significant burden
of atherosclerosis in apparently unobstructed coronary arteries.29
Diffuse atherosclerosis can cause pressure loss and this may
account for the wide-range of FFR values observed in reference
vessels (lowest obtained 0.85). It remains uncommon to routinely
perform intravascular imaging in unobstructed vessels and
therefore, together with the large number of unobstructed vessels,
our findings should be applicable to patients undergoing coronary
angiography.
Although we stratified data according to FFR and QCA DS%,
both are imperfect measures. In the presence of microcirculatory
dysfunction, FFR may underestimate true haemodynamic
stenosis significance.30 Quantitative angiography provides limited
information of the physiological impact of a given stenosis. How-
ever, both measures are easy to comprehend and familiar to
clinicians providing a familiar conceptual framework to interpret
the data.
Finally, it must be borne in mind, however, that our results are
inferred on group basis and heterogeneous factors such as micro-
vascular dysfunction and diffuse epicardial disease could obscure
these findings on a patient-specific level.31,32 Theoretically, how-
ever, any factor that impairs auto-regulatory responses to a stenosis
could also impact upon microcirculatory responses to vasodilators
such as adenosine. When there are discrepancies between resting
and hyperaemic factors, it remains unclear which parameters pro-
vide prognostic information. Randomized clinical outcome studies
are currently being undertaken to assess the safety and performance
of resting parameters to guide revascularization.33,34
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